Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives

SIMPLE SUMMARY: Glioblastoma is the most common and aggressive malignant primary brain cancer in adults. The prognosis remains poor following standard-of-care treatment with surgery, radiotherapy and chemotherapy, with a median overall survival of about 15 months. Theoretically, all glioblastoma pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Birzu, Cristina, French, Pim, Caccese, Mario, Cerretti, Giulia, Idbaih, Ahmed, Zagonel, Vittorina, Lombardi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794906/
https://www.ncbi.nlm.nih.gov/pubmed/33375286
http://dx.doi.org/10.3390/cancers13010047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794906/
https://www.ncbi.nlm.nih.gov/pubmed/33375286
http://dx.doi.org/10.3390/cancers13010047

Ejemplares similares